We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > gastrointestinal cancer

News List

I-Mab Appoints International Gastrointestinal Oncology Expert Dr. Andrew Zhu to its Scientific Advisory Board prnasia
June 22, 2021
I-Mab, a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, announced the appointment of Andrew Zhu, MD, PhD, to the Company's Scientific Advisory Board.
Oncolytics Biotech, Roche, AIO Initiate Gastrointestinal Cancer Trial americanpharmaceuticalreview
November 05, 2020
Oncolytics Biotech® announced a new multi-indication gastrointestinal (GI) cancer study to be managed by AIO. The phase 1/2 trial, known as GOBLET, will investigate the use of pelareorep, in combination with Roche's anti-PD-L1 checkpoint inhibitor ...
Keytruda cuts risk of death by 31% in esophageal cancer trial pharmaphorum
January 16, 2019
MSD’s Keytruda has cut the risk of death by 31% in patients with esophageal or esophagogastric junction carcinoma or adenocarcinoma who progressed after standard therapy.